These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 26896268)

  • 1. Multimarker risk stratification approach and cardiovascular outcomes in patients with stable coronary artery disease undergoing elective percutaneous coronary intervention.
    Mehta V; Sukhija R; Mehra P; Goyal A; Yusuf J; Mahajan B; Gupta VK; Tyagi S; Palaniswamy C; Aronow WS
    Indian Heart J; 2016; 68(1):57-62. PubMed ID: 26896268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of intravenous vitamin C infusion on periprocedural myocardial injury for patients undergoing elective percutaneous coronary intervention.
    Wang ZJ; Hu WK; Liu YY; Shi DM; Cheng WJ; Guo YH; Yang Q; Zhao YX; Zhou YJ
    Can J Cardiol; 2014 Jan; 30(1):96-101. PubMed ID: 24365194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 4a myocardial infarction: Incidence, risk factors, and long-term outcomes.
    Yang X; Tamez H; Lai C; Ho K; Cutlip D
    Catheter Cardiovasc Interv; 2017 Apr; 89(5):849-856. PubMed ID: 27535209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Periprocedural Myocardial Biomarker Elevation on Mortality Following Elective Percutaneous Coronary Intervention.
    Garcia-Garcia HM; McFadden EP; von Birgelen C; Rademaker-Havinga T; Spitzer E; Kleiman NS; Cohen DJ; Kennedy KF; Camenzind E; Mauri L; Steg PG; Wijns W; Silber S; van Es GA; Serruys PW; Windecker S; Cutlip D; Vranckx P
    JACC Cardiovasc Interv; 2019 Oct; 12(19):1954-1962. PubMed ID: 31601389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-Sensitivity Troponin T and Mortality After Elective Percutaneous Coronary Intervention.
    Ndrepepa G; Colleran R; Braun S; Cassese S; Hieber J; Fusaro M; Kufner S; Ott I; Byrne RA; Husser O; Hengstenberg C; Laugwitz KL; Schunkert H; Kastrati A
    J Am Coll Cardiol; 2016 Nov; 68(21):2259-2268. PubMed ID: 27884243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Periprocedural use of tirofiban in elective percutaneous coronary intervention for long coronary lesions in stable patients with overlapping drug-eluting stents--the PETITION study: a prospective, randomized, multicenter study.
    Zhang Q; Wang XL; Liao ML; Hu J; Yang ZK; Ding FH; Zhang JS; Du R; Zhu TQ; Shen WF; Zhang RY
    Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():762-9. PubMed ID: 25630513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence, predictors and clinical significance of periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention.
    Zhou Y; Chen Z; Ma J; Chen A; Lu D; Wu Y; Ren D; Zhang C; Dai C; Zhang Y; Qian J; Ge J
    J Cardiol; 2020 Sep; 76(3):309-316. PubMed ID: 32354492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarker release after percutaneous coronary intervention in patients without established myocardial infarction as assessed by cardiac magnetic resonance with late gadolinium enhancement.
    Vieira de Melo RM; Hueb W; Nomura CH; Ribeiro da Silva EE; Villa AV; Oikawa FTC; da Costa LMA; Rezende PC; Garzillo CL; Lima EG; Franchini Ramires JA; Kalil Filho R
    Catheter Cardiovasc Interv; 2017 Jul; 90(1):87-93. PubMed ID: 28573785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of Neutrophil to Lymphocyte Ratio With Periprocedural Myocardial Damage in Patients Undergoing Elective Percutaneous Coronary Intervention.
    Bressi E; Mangiacapra F; Ricottini E; Cavallari I; Colaiori I; Di Gioia G; Creta A; Di Sciascio G
    Am J Cardiol; 2016 Oct; 118(7):980-4. PubMed ID: 27515894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preprocedural High-Sensitivity Cardiac Troponin T and Clinical Outcomes in Patients With Stable Coronary Artery Disease Undergoing Elective Percutaneous Coronary Intervention.
    Zanchin T; Räber L; Koskinas KC; Piccolo R; Jüni P; Pilgrim T; Stortecky S; Khattab AA; Wenaweser P; Bloechlinger S; Moschovitis A; Frenk A; Moro C; Meier B; Fiedler GM; Heg D; Windecker S
    Circ Cardiovasc Interv; 2016 Jun; 9(6):. PubMed ID: 27296200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of micro troponin leak on long-term outcomes following elective percutaneous coronary intervention.
    Milani RV; Fitzgerald R; Milani JN; Lavie CJ
    Catheter Cardiovasc Interv; 2009 Nov; 74(6):819-22. PubMed ID: 19670308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and impact on prognosis of peri-procedural myocardial infarction in 2760 elective patients with stable angina pectoris in a historical prospective follow-up study.
    Christensen MK; Huang H; Torp-Pedersen C; Trydal T; Ravkilde J
    BMC Cardiovasc Disord; 2016 Jun; 16():140. PubMed ID: 27305902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of long-term statin therapy on postprocedural myocardial infarction in patients undergoing nonemergency percutaneous coronary intervention.
    Gordin J; Haider A; Swaminathan RV; Kim LK; Minutello RM; Bergman G; Wong SC; Feldman DN
    Am J Cardiol; 2012 Nov; 110(10):1397-404. PubMed ID: 22858186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Value of High-sensitivity Troponin T After Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease.
    Ndrepepa G; Braun S; Cassese S; Mayer K; Lohaus R; Lahmann AL; Fusaro M; Laugwitz KL; Schunkert H; Kastrati A
    Rev Esp Cardiol (Engl Ed); 2016 Aug; 69(8):746-53. PubMed ID: 27230475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of remote ischemic preconditioning on serum troponin T level following elective percutaneous coronary intervention.
    Ahmed RM; Mohamed el-HA; Ashraf M; Maithili S; Nabil F; Rami R; Mohamed TI
    Catheter Cardiovasc Interv; 2013 Nov; 82(5):E647-53. PubMed ID: 23404916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The randomized clinical trial of coenzyme Q10 for the prevention of periprocedural myocardial injury following elective percutaneous coronary intervention.
    Aslanabadi N; Safaie N; Asgharzadeh Y; Houshmand F; Ghaffari S; Garjani A; Dousti S; Hamishehkar H; Entezari-Maleki T
    Cardiovasc Ther; 2016 Aug; 34(4):254-60. PubMed ID: 27214383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Chia S; Senatore F; Raffel OC; Lee H; Wackers FJ; Jang IK
    JACC Cardiovasc Interv; 2008 Aug; 1(4):415-23. PubMed ID: 19463339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosuvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of myocardial periprocedural necrosis: the ROMA trial.
    Sardella G; Conti G; Donahue M; Mancone M; Canali E; De Carlo C; Di Roma A; Calcagno S; Lucisano L; Fedele F
    Catheter Cardiovasc Interv; 2013 Jan; 81(1):E36-43. PubMed ID: 22517610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different cardiac biomarkers to detect peri-procedural myocardial infarction in contemporary coronary stent trials: impact on outcome reporting.
    Vranckx P; Farooq V; Garg S; Van Es GA; Silber S; Windecker S; Stone GW; Serruys PW
    Heart; 2012 Oct; 98(19):1424-30. PubMed ID: 22821273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of baseline C-reactive protein levels with periprocedural myocardial injury in patients undergoing percutaneous bifurcation intervention: a CACTUS study subanalysis.
    Niccoli G; Sgueglia GA; Latib A; Crea F; Colombo A;
    Catheter Cardiovasc Interv; 2014 Jan; 83(1):E37-44. PubMed ID: 23813627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.